Výsledky vyhledávání - "Caitlin Joffe"

Supplemental Table 1 from A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis

Autor: Nilofer S. Azad, Lillian L. Siu, Naomi Horiba, Sarah Temkin, Alice Chen, Lihua Wang, Robert J. Kinders, Amy Hacker-Prietz, Emily Petito, Caitlin Joffe, Angela Scardina, Laura A. Dawson, Anthony Brade, Marianna Zahurak, Joseph M. Herman, Kim A. Reiss

Treatment regimens, platinum-sensitivity and BRCA status of ovarian and fallopian tube cancer patients.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c211a3a46f86298df406217c5880786
https://doi.org/10.1158/1078-0432.22455387.v1

Zobrazit plný text záznamu

Supplemental Table 2 from A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis

Sites of disease and progression of all patients.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f47c10bcfa0252aa715e07bcfd6eb9
https://doi.org/10.1158/1078-0432.22455384.v1

Zobrazit plný text záznamu

Supplemental Table 3 from A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis

Quality of life (QoL) t-tests for all patients (A), GYN versus non-GYN patients (B) and patients who completed cycle 2 and those who did not (C).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31c85a0cd1432ab1573ef6017fa7896d
https://doi.org/10.1158/1078-0432.22455381

Zobrazit plný text záznamu

Supplemental Figure Legend from A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28d74be4ec1b4ad2c3b90d0a9603b7f5
https://doi.org/10.1158/1078-0432.22455390.v1

Zobrazit plný text záznamu

Data from A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis

Purpose: The combination of low-dose radiotherapy with PARP inhibition has been shown to enhance antitumor efficacy through potentiating DNA damage. We combined low-dose fractionated whole abdominal radiation (LDFWAR) with escalating doses of velipar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9a50bb94be1efa2d9579804b950a777
https://doi.org/10.1158/1078-0432.c.6523011.v1

Zobrazit plný text záznamu

Supplemental Figure 1 from A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis

CTC number and ɣ-H2AX-positive CTC changes during treatment with radiotherapy and veliparib.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba9f16b885cd0ff1292cbba51144816c
https://doi.org/10.1158/1078-0432.22455393

Zobrazit plný text záznamu

A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosis

Autor: Marianna Zahurak, Laura A. Dawson, Alice P. Chen, Robert J. Kinders, Kim A. Reiss, Anthony Brade, Joseph M. Herman, Angela Scardina, Nilofer S. Azad, Caitlin Joffe, Lihua Wang, Emily Petito, Amy Hacker-Prietz, Sarah M. Temkin, Lillian L. Siu, Naomi Horiba

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 21(1)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f890a830a0ae4ac995fc0c98ffbcffc9
https://pubmed.ncbi.nlm.nih.gov/25355929

Zobrazit plný text záznamu

Final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers

Autor: Angela Scardina, Anthony Fyles, Naomi Horiba, Lee-Anne Stayner, Kim A. Reiss, Michael Milosevic, Emily Petito, Amy Hacker-Prietz, Robert J. Kinders, Lihua Wang, Caitlin Joffe, Nilofer S. Azad, Joseph M. Herman, Alice P. Chen, Marianna Zahurak, Sarah M. Temkin

Publikováno v: Journal of Clinical Oncology. 34:2584-2584

2584Background: Combining low-dose radiation therapy with poly (ADP-ribose) polymerase (PARP) inhibition has been shown to enhance anti-tumor efficacy through potentiating DNA damage in tumor cells...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4d9e74c95d13e579c4693418463c0996
https://doi.org/10.1200/jco.2016.34.15_suppl.2584

Zobrazit plný text záznamu

A phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis

Autor: Nilofer S. Azad, Anthony Brade, Emily Petito, Amy Hacker-Prietz, Laura A. Dawson, Naomi Horiba, Angela Scardina, Caitlin Joffe, Lillian L. Siu, Sarah M. Temkin, Marianna Zahurak, Alice P. Chen, Joseph M. Herman, Kim A. Reiss

Publikováno v: Journal of Clinical Oncology. 32:4139-4139

4139 Background: The combination of low-dose radiation therapy with poly (ADP-ribose) polymerase (PARP) inhibition has been shown to enhance anti-tumor efficacy through potentiating DNA damage in tumor cells. In this phase I study, we combined low do

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1111a47b1dc3eda0cc22e0ebec44eff4
https://doi.org/10.1200/jco.2014.32.15_suppl.4139

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání